That is, under albumin supplementation, patients with higher albumin levels tended to exhibit higher risks of mortality, shock, heart failure, and pulmonary edema, whereas albumin supplementation did not exert any significant influence on patients with severe hypoalbuminemia (0.0–1.0 g/dL). This evidence concerns the gene ALB and Hypoalbuminemia.